Abstract: PET/CT with 68 Ga-labeled prostate-specific membrane antigen (PSMA) is increasingly recognized as the best imaging modality for disease staging and detection of recurrent prostate cancer. Despite its name, PSMA expression has been reported in a number of nonprostatic benign and malignant pathologies. Apparently, angioneogenesis is the mechanism attributed to increased 68 Ga-PSMA uptake at these sites. Here we illustrate the utility of 68 Ga-PSMA in 5 nonprostatic malignancies that could open up new possibilities for diagnostics and theranostic concepts with PSMA labeled radioligands in nonprostate tumor entities.
FIGURE 1.
A 78-year-old man, case of adenocarcinoma gastroesophageal junction, underwent 68 Ga-labeled prostate-specific membrane antigen (PSMA)-PET/CT (maximum intensity projection [MIP], A) for elevated prostate-specific antigen levels (19.75 ng/mL), which revealed intense tracer uptake in the distal esophagus (B-D, arrows), gastroesophageal junction, and stomach (E-G, arrows). Focal PSMA uptake was also noted in the right lobe of the prostate (H-J, dotted arrows), which revealed adenocarcinoma on pathology. Prostate-specific membrane antigen uptake had been reported in multiple nonprostatic malignancies. 1, 2 Significant neovascularization is reported in gastric cancers, leading to increased PSMA expression. 3 The significant angioneogenesis in gastric cancer can be potentially used for imaging with PSMA-PET/CT and PSMA-directed therapy in nonoperable cases.
FIGURE 2.
A 70-year-old man, case of dual malignancy (carcinoma urinary bladder and prostate), underwent 18 F-fluorodeoxyglucose (FDG)-PET/CT (MIP, A) for metastatic workup, which showed FDG-avid lesion in the left internal iliac region (B-C, arrow), pelvic, and retroperitoneal lymph nodes (D-G, dotted-arrow). To ascertain the nature, PSMA-PET/CT (MIP, H) was performed, which revealed PSMA avidity in the left iliac lesion (I-J, arrow), whereas no tracer uptake was observed in the rest (right internal iliac and paraaortic; K-N, dotted arrow) of the lymph nodes. Biopsy from the iliac lesion revealed metastatic carcinoma from urinary bladder. Prostate-specific membrane antigen avidity has been reported in adenocarcinoma of the urinary bladder. 4 This case highlights the differential expression of PSMA on neovasculature of metastatic site but not on lymph nodes with absence of neovascularization.
